Changing practice patterns in the management of acute myocardial infarction complicated by cardiogenic shock: Elderly compared with younger patients

Canadian Journal of Cardiology

Volumn 14, Issue 7, 1998, Pages 923-930

  Džavík, Vladimír ^a,b   Burton, Jeffrey R ^a   Kee, Cheryl ^a   Teo, Koon K ^a   Ignaszewski, Andrzej ^a   Lucas, Alexandra R ^a   Tymchak, Wayne J ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

^b UNIVERSITY OF ALBERTA   (Canada)

Author keywords

Cardiogenic shock; Elderly patients; Practice patterns; Revascularization

Indexed keywords

CREATINE KINASE; FIBRINOLYTIC AGENT;

ACUTE HEART INFARCTION; ADULT; AGE; AGED; ANGIOCARDIOGRAPHY; AORTA BALLOON; ARTICLE; CARDIOGENIC SHOCK; CLINICAL PRACTICE; CONTROLLED STUDY; CORONARY ARTERY BYPASS SURGERY; CREATINE KINASE BLOOD LEVEL; FEMALE; FIBRINOLYTIC THERAPY; HEART CATHETERIZATION; HEART RATE; HOSPITAL PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; RETROSPECTIVE STUDY; REVASCULARIZATION; STATISTICAL ANALYSIS; STENOSIS; SURVIVAL; TRANSLUMINAL CORONARY ANGIOPLASTY; TREATMENT OUTCOME;

AGE FACTORS; CORONARY ANGIOGRAPHY; HUMANS; MYOCARDIAL INFARCTION; MYOCARDIAL REVASCULARIZATION; PHYSICIAN'S PRACTICE PATTERNS; RETROSPECTIVE STUDIES; SHOCK, CARDIOGENIC; SURVIVAL RATE;

EID: 0031827461     PISSN: 0828282X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. Agress CM, Binder MJ. Cardiogenic shock Am Heart J 1957;54:458-77.
2. Kuhn LA. The treatment of cardiogenic shock. I. The nature of cardiogenic shock. Am Heart J 1967;74:578-81.
3. Berger PB, Holmes DR Jr, Stebbins AL, Bates ER, Califf RM, Topol EJ. Impact of an aggressive invasive catheterization and revascularization strategy on mortality in patients with cardiogenic shock in the Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries (GUSTO-1) trial. An observational study. Circulation 1997;96:122-7.
4. Goldberg RJ, Gore JM, Alpert JS, et al. Cardiogenic shock after acute myocardial infarction. Incidence and mortality from a community-wide perspective, 1975 to 1988. N Engl J Med 1991;325:1117-22.
5. Holmes DR Jr, Bates ER, Kleiman NS, et al. Contemporary reperfusion therapy for cardiogenic shock: the GUSTO-1 trial experience. The GUSTO-1 Investigators. J Am Coll Cardiol 1995;26:668-74.
6. Gacioch GM, Ellis SG, Lee L, et al. Cardiogenic shock complicating acute myocardial infarction: the use of coronary angioplasty and the integration of the new support devices into patient management. J Am Coll Cardiol 1992;19:647-53.
7. Hibbard MD, Holmes DR Jr, Bailey KR, Reeder GS, Bresnahan JF, Gersh BJ. Percutaneous transluminal coronary angioplasty in patients with cardiogenic shock. J Am Coll Cardiol 1992;19:639-46.
8. Hands ME, Rutherford JD, Muller JE, et al. The in-hospital development of cardiogenic shock after myocardial infarction: incidence, predictors of occurrence, outcome and prognostic factors. The MILIS Study Group. J Am Coll Cardiol 1989;14:40-6.
9. Hochman JS, Boland J, Sleeper LA, et al. Current spectrum of cardiogenic shock and effect of early revascularization on mortality Results of an international registry. SHOCK Registry Investigators. Circulation 1995;91:873-81.
10. Moosvi AR, Khaja F, Villanueva L, Gheorghiade M, Douthat L, Goldstein S. Early revascularization improves survival in cardiogenic shock complicating acute myocardial infarction. J Am Coll Cardiol 1992;19:907-14.